Solving the Puzzle of Metastasis: The Evolution of Cell Migration in Neoplasms

Background Metastasis represents one of the most clinically important transitions in neoplastic progression. The evolution of metastasis is a puzzle because a metastatic clone is at a disadvantage in competition for space and resources with non-metastatic clones in the primary tumor. Metastatic clones waste some of their reproductive potential on emigrating cells with little chance of establishing metastases. We suggest that resource heterogeneity within primary tumors selects for cell migration, and that cell emigration is a by-product of that selection. Methods and Findings We developed an agent-based model to simulate the evolution of neoplastic cell migration. We simulated the essential dynamics of neoangiogenesis and blood vessel occlusion that lead to resource heterogeneity in neoplasms. We observed the probability and speed of cell migration that evolves with changes in parameters that control the degree of spatial and temporal resource heterogeneity. Across a broad range of realistic parameter values, increasing degrees of spatial and temporal heterogeneity select for the evolution of increased cell migration and emigration. Conclusions We showed that variability in resources within a neoplasm (e.g. oxygen and nutrients provided by angiogenesis) is sufficient to select for cells with high motility. These cells are also more likely to emigrate from the tumor, which is the first step in metastasis and the key to the puzzle of metastasis. Thus, we have identified a novel potential solution to the puzzle of metastasis.

[1]  John M L Ebos,et al.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. , 2009, Cancer cell.

[2]  Frederik De Smet,et al.  Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization , 2009, Cell.

[3]  V. Quaranta,et al.  Microenvironment driven invasion: a multiscale multimodel investigation , 2009, Journal of mathematical biology.

[4]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[5]  T. Antal,et al.  The emergence of tumor metastases , 2007, Cancer biology & therapy.

[6]  Darryl Shibata,et al.  Counting Divisions in a Human Somatic Cell Tree: How, What and Why , 2006, Cell cycle.

[7]  Mauro Ferrari,et al.  Multiparameter computational modeling of tumor invasion. , 2009, Cancer research.

[8]  A. Anderson,et al.  Evolution of cell motility in an individual-based model of tumour growth. , 2009, Journal of theoretical biology.

[9]  René Bernards,et al.  A progression puzzle. , 2002, Nature.

[10]  Siqing Shan,et al.  The pervasive presence of fluctuating oxygenation in tumors. , 2008, Cancer research.

[11]  K. Giehl.  Oncogenic Ras in tumour progression and metastasis , 2005, Biological chemistry.

[12]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[13]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[14]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[15]  Richard P. Hill,et al.  Acute Hypoxia Enhances Spontaneous Lymph Node Metastasis in an Orthotopic Murine Model of Human Cervical Carcinoma , 2004, Cancer Research.

[16]  G. Fuller,et al.  Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice , 2010, Neuro-oncology.

[17]  E. Rofstad,et al.  Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  L. Soon.  A discourse on cancer cell chemotaxis: Where to from here? , 2007, IUBMB life.

[19]  Martin A. Nowak,et al.  Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.

[20]  D L S McElwain,et al.  New insights into vascular collapse and growth dynamics in solid tumors. , 2004, Journal of theoretical biology.

[21]  Tracy T Batchelor,et al.  AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.

[22]  Robert A. Gatenby,et al.  Modelling a new angle on understanding cancer , 2002, Nature.

[23]  Masahiro Inoue,et al.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.

[24]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[25]  T. Benton,et al.  Causes and consequences of animal dispersal strategies: relating individual behaviour to spatial dynamics , 2005, Biological reviews of the Cambridge Philosophical Society.

[26]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[27]  I. Fidler,et al.  Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.

[28]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[29]  Martin A Nowak,et al.  Stochastic dynamics of metastasis formation. , 2006, Journal of theoretical biology.

[30]  Ruth Etzioni,et al.  Early detection: The case for early detection , 2003, Nature Reviews Cancer.

[31]  E. Rofstad,et al.  Fluctuating and Diffusion-Limited Hypoxia in Hypoxia-Induced Metastasis , 2007, Clinical Cancer Research.

[32]  U. Lendahl,et al.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.

[33]  Joshy George,et al.  Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.

[34]  W. Kendal,et al.  The role of multiple somatic point mutations in metastatic progression. , 1992, Mathematical biosciences.

[35]  D. Buerk,et al.  Microvascular and tissue oxygen gradients in the rat mesentery. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Vaupel,et al.  Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. , 2004, The oncologist.

[37]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[38]  R A Rifkind,et al.  Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. , 2000, Cancer research.

[39]  D. Brizel,et al.  Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[41]  R. Hill,et al.  Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.

[42]  Lei Xu,et al.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. , 2004, Cancer cell.

[43]  Robert S Kerbel.  Tumor angiogenesis. , 2008, The New England journal of medicine.

[44]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[45]  S. McMahon,et al.  Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Jong-Hyeon Jeong,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.

[47]  Rakesh K. Jain,et al.  Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.

[48]  U. Netlogo Wilensky,et al.  Center for Connected Learning and Computer-Based Modeling , 1999 .

[49]  E. Rofstad,et al.  Temporal heterogeneity in oxygen tension in human melanoma xenografts , 2003, British Journal of Cancer.

[50]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.